Heiq Share Discussion Threads

[bad gateway] 08/7/2021 14:49

Masks have moved beyond needing to be mandatory imo they've become part of the great unwashed's psyche.

[dr biotech] 08/7/2021 14:35

Mask sales are only a relatively small part of total revenue. Any drop there should be compensated by other coatings as people by more clothes for social reasons.

Looks like full scale capitulation today, I’ve added a few more at 133 hope it’s not going to fall much further.

[pugugly] 08/7/2021 12:49

jammytas - Why do you ask that? I have seen nothing in that area.

Fall might be due the possible future decline in use of masks and thus significant fall in sales of products incorporating Viroblock

[jammytass] 08/7/2021 12:24

Is there a patent infringement?

[petewy] 08/7/2021 11:22

Next stop 120p?

[pugugly] 08/7/2021 08:56

Dr B - See page 46 of the Progressive Note
"Short Polymer Fibres"
"Microcomposite powders"
"Funcional particles"
Has created uncertainty in my mind -

[bad gateway] 07/7/2021 21:13

Did well to pull back to support line once the sellers cleared and getting more oversold but no conviction to the upside as yet.
Undecided myself whether to hold or fold.

free stock charts from uk.advfn.com

[pugugly] 07/7/2021 16:17

Revisit on continuous fall from high of 240 feb 21 to 152/1451/7/21 p/e avfn 49 - far too high – growth potential but no real indication – mask hyped.
7/7/21 Volume to the sell side - 122,445 -v-8,121 subject to algorithm attribution
Almost looks like a sell tip out there - Knowledge?

Or could it be the impact of "No masks Boris" potentially destroying their mask business?

[pugugly] 07/7/2021 14:53

12 week break-out DOWN- Over hyped and over here - (imo) Still one to watch but not yet and needs far more DD in respect of ESG risk - ?? plastic fillers for fabrics? Possible source of polluting micro-fibres
Cannot find any information in this area on their website - Anyone any knowledge and/or links?

[bad gateway] 02/7/2021 20:59

Playing out as a broadening wedge so good to see the support today. Picked a few up for trading as quite so oversold. See how she rides.


free stock charts from uk.advfn.com

[dr biotech] 02/7/2021 16:20

Volume is nothing special nor is the number of trades. Some of the recent sales may be the end of a lock-in after the flotation as often various parties have to hold for a minimum of 6months. I haven’t trawled the IPO documents though.

[spectoacc] 02/7/2021 15:03

A buy or a sell tip........ ;)

[pugugly] 02/7/2021 14:52

Much more action than usual - Must have been tipped somewhere - Any knowledge as to the tipster - Was a SCSW but their next issue not due until July 10th

[dr biotech] 01/7/2021 16:48

PE is only 50 if you assume the one off costs I’d listing are repeated, which they won’t be. Still gas a lot to prove - I’m sitting on a moderate loss here and will wait for the next trading update to see how their partnerships are developing.

[pugugly] 01/7/2021 16:16

Still grossly overvaued (IMO) historic p/e 50 - Constant 5 day faller - Masks are probably a red-herring - No real sign of traction.

OK initial hype as sector transformational but very little actionable news (imo)

[geraldus] 01/7/2021 16:03

This is turning into a rout.Needs some big news.

[mmb007] 30/6/2021 12:16

1H numbers should be available mid July, so there should be an update either way from there. Masks are a relatively small % of the earnings so should not really be a share price driver. Key will be the conversion of new customers, acquisitions and Virobloc contracts.

[earwacks] 30/6/2021 11:42

Not only that, some of the cheap brand face masks apparently are next to useless. Trouble is when the share price falls like this its hard to work out if the bigger trades are buys or sells. Initially it looked like share price was falling on small sells but more than normal UT trades too. I think will just have to weather this storm as not bing anything specific, but random trigger of analogue trading.
June 9, 2021
KARMAN, a French supplier of healthcare and hygiene products, has joined forces with HeiQ, to launch the KARMAN ACTIV’PROTECT mask. This disposable Type IIR mask uses HeiQ’s patented HeiQ Viroblock textile technology. This technology gives the textiles of the KARMAN ACTIV’ PROTECT masks safe and permanent antimicrobial and antiviral properties, especially against SARS-CoV-2.
June 22: LIFE’s 40+ products strengthen HeiQ’s global product offering and will facilitate HeiQ’s existing technology platforms into new markets, especially masterbatches, plastics and coatings. Leading manufacturers and brands, such as DuPont, American Standard, Igloo Products, Marks & Spencer, John Lewis, and Columbia Sportswear use LIFE’s antimicrobial additives. Through LIFE, HeiQ will also have access to hygiene technologies, such as odor absorbent additives, that complement HeiQ’s core antimicrobial technology. With the acquisition, HeiQ will now have additional offices and laboratories in Thailand and Brazil.

[melton john] 30/6/2021 11:01

Agree, this isn't a one-trick pony, and in any case, face masks are going to be a feature of life for a long time with mutations and also developing better ones as featured in recent news.

[dr biotech] 30/6/2021 10:47

Like to think any loss of facemasks would be more than compensated by improvements in other textiles. But this is currently friendless.

Probably due a trading update in mid-late July.

[melton john] 30/6/2021 10:23

I just spent an idle 600 quid from a dividend in my ISA. TA indicates it's oversold, on the other hand it could fall through 200 MA.

[earwacks] 30/6/2021 10:05

I guess it only takes 1 seller. Peel Hunt target 2.40. Strange share price reaction to AGM

[edwardt] 30/6/2021 09:11

guess market thinks the covid bounce in face masks will be one off earning hike. i disagree.

[petewy] 16/6/2021 11:49

Acquisition of Life Material Technologies

HeiQ announced the acquisition of Life Material Technologies, Hong Kong, (LIFE) on 15 June, a move which will strengthen its antimicrobial technologies platform. The initial consideration is $6.45m with a potential earn-out consideration payable in 2022 of up to $2.8m. LIFE’s antimicrobial technologies are applicable not only to textiles, with some notable retailers in its customer base, but also to polymers and other coatings, thereby complementing HeiQ’s push into materials beyond textiles and supporting its ambition of becoming a global leader in materials innovation.